KDM1 is a novel therapeutic target for the treatment of gliomas.
Sareddy GR, Nair BC, Krishnan SK, Gonugunta VK, Zhang QG, Suzuki T, Miyata N, Brenner AJ, Brann DW, Vadlamudi RK.
Sareddy GR, et al. Among authors: brenner aj.
Oncotarget. 2013 Jan;4(1):18-28. doi: 10.18632/oncotarget.725.
Oncotarget. 2013.
PMID: 23248157
Free PMC article.